Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cloyd, J. C.
Right arrow Articles by Eggerth, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cloyd, J. C.
Right arrow Articles by Eggerth, R. M.
NEUROLOGY 1983;33:185
© 1983 American Academy of Neurology

Pharrnacokinetics of valproic acid in children

I. Multiple antiepileptic drug therapy

James C. Cloyd, PharmD, Robert L. Kriel, MD, James H. Fischer, PharmD, Ronald J. Sawchuk. PhD and Rose M. Eggerth, BS

Departrncnts of Pediatric Neurology and Pharmaceutical Services. St. Paul-Ramscy Medical Center, and the Department of Pharmaceuties, College of Pharmacy. and Division of Pediatric Neurology. University of Minnesota, Minneapolis. MN.

We studied the pharmacokinetics of valproic acid (VPA) in 37 children who were taking other antiepileptic drugs. Thirteen children were studied both after initial and while on maintenance valproic acid therapy. Significant differences occurred between initial and maintenance therapy in the mean apparent volume of distribution and in apparent VPA clearance, whereas VPA half-life remained relatively constant. Analysis of data in the 13 children studied on two occasions demonstrated wide intrapatient variability of VPA pharmacokinetics. Children taking VPA together with other antiepileptic medications generally require higher doses of VPA given more frequently.

Address correspondence and reprint requests t.o Dr. Cloyd, Department Of Pharmaceutical Services, St-Paul-Ramsey Medical Center, 640 Jackson Street, St. Paul, MN 55101.

This study was supported in part by a grant from the Epilepsy Foundation of America and the Medical Education and Research Foundation of St. Paul-Ramsey Medical Center.

Accepted for publication June 24, 1982.




This article has been cited by other articles:


Home page
NeurologyHome page
S. R. Cowdery, D. C. Preston, D. N. Herrmann, and E. L. Logigian
Electrodiagnosis of ulnar neuropathy at the wrist: Conduction block versus traditional tests
Neurology, August 13, 2002; 59(3): 420 - 427.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. G. Bradley, R. K. Bennett, P. Good, and B. Little
Proximal Chronic Inflammatory Polyneuropathy With Multifocal Conduction Block
Arch Neurol, April 1, 1988; 45(4): 451 - 455.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.